Amy Bachrodt

SVP, Finance, Maze Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$1.6M

Companies

Latest trade

Apr 1, 2026

Companies

Maze Therapeutics, Inc.SVP, Finance −$1.6M

Trades

MAZE Sold 2,500 shares at $29.44 · planned $0.1M Apr 1

MAZE Sold 5,000 shares at $45.20 · planned $0.2M Mar 2

MAZE Sold 5,000 shares at $46.04 · planned $0.2M Feb 2

MAZE Sold 5,000 shares at $45.52 · planned $0.2M Jan 22

MAZE Sold 5,000 shares at $39.15 · planned $0.2M Jan 2

MAZE Sold 5,000 shares at $40.08 · planned $0.2M Dec 30

MAZE Sold 10,000 shares at $40.58 · planned $0.4M Dec 29

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.